2023 Scientific Program On Demand

Managing the AF Epidemic: From Prediction to Prevention and Access
Moderators: Daniel Singer, MD and Andrea Russo, MD

Risk Factor Modification: From A3 to SORT-AF - Where do We Go from Here
Jonathan Kalman, MD

Have Consumer Devices Eliminated the Need for Implantable Recorders for AF Detection
Andrea Russo, MD

Data Collection and Management with Wearables & Implantables for AF: Clinical Workflow; Applications of AI & Deep Learning
Rod Passman, MD

How to Manage Incidental Device Detected AF and Device Detected AF in Patients with CHF
Kenneth Ellenbogen, MD

Use of Artificial Intelligence for Prediction of Incident Atrial Fibrillation
Shaan Khurshid, MD

Q&A, Panel and Audience Discussion

SPOTLIGHT SESSION I
Early Stage and Emerging Technologies in Cardiac EP
Moderator: Paul Wang, MD

Personalizing AF Ablation Based on CT: Isodistances and Wall Thickness (ADAS 3D Medical SL)
Diego Penela, MD

Rapid IV Loading of Sotalol-A Disruptive Therapy for Atrial Fibrillation (AltaThera Pharmaceuticals)
Bradley Knight, MD

Epicardial Ablation of Ganglionated Plexi for the Treatment of Atrial Fibrillation (AtriAN Medical)
Vivek Reddy, MD

The AcQBlate FORCE (AlCath Force) Sensing Ablation Catheter (Acutus Medical)
Robert Bernat, MD

A New Solution for Efficient PVI Achieved Through Conformance, Stability, and Direct Visualization-HeartLight X3 (CardioFocus)
David Haines, MD

Artificial Intelligence Enabled Platforms in Cardiovascular Medicine (Anumana-NeuTrace)
Kalyanam Shivkumar, MD, PhD

Highlights of the Latest Advances in the Philips KODEX-EPD System (EPD Systems-A Philips Company)
Andreas Rillig, MD

In-Vitro and In-Vivo Preclinical Evaluation of Pulsed Field Ablation with a Circular Linear Ablation Catheter (EP Frontiers)
Jonathan Piccini, MD

Predicting Durability of PFA Lesions Using an Optically Guided Catheter (MedLumics)
Atul Verma, MD

Bridging Knowledge Gaps to Facilitate Clinical Evidence Generation for New AF Ablation Technologies
Speaker: Jun Dong, MD, Medical Officer, Office of Cardiovascular Devices, CDRH, US FDA

Real-Time and Prerecorded Case Transmissions – Session I
Moderators: Moussa Mansour, MD and David Keane, MD, PhD
Panel: Gerhard Hindricks, MD, Pierre Jais, MD, Devi Nair, MD, Andrea Natale, MD, Vivek Reddy, MD

AF Ablation Using a Radiofrequency Balloon Catheter (HELIOSTAR Biosense Webster)
Jean Baptiste Chierchia, MD, Heart Rhythm Management Center, Brussels, Belgium

Left Atrial Appendage Closure with the Amulet Device (Abbott)
Dhanunjaya Lakkireddy, MD, Kansas City Heart Rhythm Institute, Kansas City, KS

Ultra-High Power Short Duration AF Ablation (QDOT & Octarray Biosense Webster)
Srinivas Dukkipati, MD, Mount Sinai Medical Center, New York, NY

Pulsed Field Ablation for AF Using a Circular Multielectrode Catheter (VARIPULSE Biosense Webster)
Charles Athill, MD, Sharp Memorial Hospital, San Diego, CA

Pulsed Field Ablation for AF Using a 9mm Lattice-Tip Catheter PFA Sphere (Affera/Medtronic)
Moussa Mansour, MD, Massachusetts General Hospital, Boston, MA

Optimizing Lesions for RF Ablation in Atrial Fibrillation
Supported by an educational grant from Abbott
Moderators: John Day, MD and Claudio Tondo, MD
All lectures 7 minutes. Q&A, Panel and Audience Discussion 25 minutes .

Protocols for High-Power Short Duration RF Ablation
Isabel Deisenhofer, MD

Optimal Approaches to Thick Areas of Atrial Anatomy - Epicardial, Roof and Mitral Isthmus Ablation
Justo Julia Calvo, MD

Alcohol Vein of Marshall Ablation
Miguel Valderrabano, MD

Safety Aspects Associated with Deep Ablation Strategies/Lesions
Saman Nazarian, MD

ERASE-AF: Low-Voltage Myocardium-Guided Ablation Trial of Persistent AF
Helmut Pürerfellner, MD

Q&A, Panel and Audience Discussion

Stroke Risk Management in Atrial Fibrillation
Session I
Supported by an educational grant from Boston Scientific
Moderators: Devi Nair, MD and Jacqueline Saw, MD

LAA Closure in Patients with Prior Intracranial Hemorrhage
Moussa Mansour, MD

Half Dose DOAC and Aspirin for Patients with LAA Closure Devices
Andrea Natale, MD

Future Directions in LAA Closure: Antithrombotic Coating and Avoidance of Anticoagulation
Aloke Finn, MD

Stroke Severity after Left Atrial Appendage Closure vs Oral Anticoagulants
Vivek Reddy, MD

Combined Left Atrial Appendage Closure & AF Ablation (With or Without LAA Isolation) - Patient Selection, Timing and Logistics
Walid Saliba, MD

Q&A, Panel & Audience Discussion - All faculty & Andrew Farb, MD, Chief Medical Officer, Office of Cardiovascular Devices, CDRH, US FDA

Stroke Risk Management in Atrial Fibrillation
Session II
Moderators: Jacqueline Saw, MD and Bradley Knight, MD

Peri-Device Leaks with LAA Closure Devices – Incidence, Physiology and Management
Rodney Horton, MD

LAA Closure Device Design (Disc & Lobe vs Plug): Selection and Anatomic Challenges
Amulet vs Watchman Clinical Trial Results (SWISS-APERO Study & Amulet US IDE Study) Challenging Anatomies; Anticoagulation; Future directions
Christopher Ellis, MD

How to Use ICE Guidance for LAA Closure Procedures: Techniques; 2D vs 4D ICE, Preprocedural Imaging
Devi Nair, MD

Complications of LAA Closure Procedures (Embolization, Effusions, Other): Strategies for Management
Jacqueline Saw, MD

Factor XIa Inhibitors: Rationale, Efficacy, and Safety
Elaine Hylek, MD

Q&A, Panel & Audience Discussion